Mologic is proud to announce it has been selected to be part of SBRI Healthcare.

This is a National Health Service England funded initiative to develop innovative products that address unmet health needs.

Mologic is one of 14 companies selected to share £1.4 million funding to develop products that can significantly impact the increasing pressures being put on urgent and emergency care services.

We will be working hard on technology which can be applied to address major healthcare challenges.

The purpose of the initiative is to reduce admissions coming into Accident & Emergency Departments.

See the SBRI Heathcare announcement here:



Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. We work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.

Our Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology. The creativity, insight and knowledge that led to that ground-breaking invention has guided Mologic since our formation in 2003.